These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Michaelis-Menten elimination kinetics: areas under curves, steady-state concentrations, and clearances for compartment models with different types of input. Wagner JG; Szpunar GJ; Ferry JJ Biopharm Drug Dispos; 1985; 6(2):177-200. PubMed ID: 4005396 [TBL] [Abstract][Full Text] [Related]
6. The assessment of bioavailability in the presence of nonlinear elimination. Hall SD; McAllister CB; Wilkinson GR J Pharmacokinet Biopharm; 1988 Jun; 16(3):263-78. PubMed ID: 3221326 [TBL] [Abstract][Full Text] [Related]
7. The influence of drug kinetics in blood on the calculation of oral bioavailability in linear pharmacokinetics: the traditional equation may considerably overestimate the true value. Berezhkovskiy LM J Pharm Sci; 2006 Apr; 95(4):834-48. PubMed ID: 16493592 [TBL] [Abstract][Full Text] [Related]
8. New and simple method to predict dosage of drugs obeying simple Michaelis-Menten elimination kinetics and to distinguish such kinetics from simple first order and from parallel Michaelis-Menten and first order kinetics. Wagner JG Ther Drug Monit; 1985; 7(4):377-86. PubMed ID: 4082237 [TBL] [Abstract][Full Text] [Related]
12. Application of modified Michaelis - Menten equations for determination of enzyme inducing and inhibiting drugs. Saganuwan SA BMC Pharmacol Toxicol; 2021 Oct; 22(1):57. PubMed ID: 34635182 [TBL] [Abstract][Full Text] [Related]
13. A new model-independent physiological approach to study hepatic drug clearance and its applications. Chiou WL Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376 [TBL] [Abstract][Full Text] [Related]
14. On the identification of Michaelis-Menten elimination parameters from a single dose-response curve. Godfrey KR; Fitch WR J Pharmacokinet Biopharm; 1984 Apr; 12(2):193-221. PubMed ID: 6491901 [TBL] [Abstract][Full Text] [Related]
15. Drug input rate from the GI-tract. Michaelis-Menten kinetics and the bioavailability of slow release verapamil and nifedipine. Woodcock BG; Menke G; Fischer A; Köhne H; Rietbrock N Drug Des Deliv; 1988 May; 2(4):299-310. PubMed ID: 3255321 [TBL] [Abstract][Full Text] [Related]
16. A computer simulation of the food effect: transient changes in hepatic blood flow and Michaelis-Menten parameters as mediators of hepatic first pass metabolism and bioavailability of propranolol. Semple HA; Tam YK; Coutts RT Biopharm Drug Dispos; 1990; 11(1):61-76. PubMed ID: 2322637 [TBL] [Abstract][Full Text] [Related]
17. [The bioavailability of orally administered drugs with special regard to the liver as a filter for foreign matter]. Raaflaub J Schweiz Med Wochenschr; 1980 Mar; 110(10):354-62. PubMed ID: 7394464 [TBL] [Abstract][Full Text] [Related]
19. In silico drug absorption tract: An agent-based biomimetic model for human oral drug absorption. Deng J; Jhandey A; Zhu X; Yang Z; Yik KFP; Zuo Z; Lam TN PLoS One; 2018; 13(8):e0203361. PubMed ID: 30169515 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic model for N-nitrosodimethylamine based on Michaelis-Menten constants determined with the isolated perfused rat liver. Skipper PL; Tomera JF; Wishnok JS; Brunengraber H; Tannenbaum SR Cancer Res; 1983 Oct; 43(10):4786-90. PubMed ID: 6883335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]